BioRestorative Therapies
BRTX
12 hedge funds and large institutions have $404K invested in BioRestorative Therapies in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0% more funds holding
Funds holding: 12 → 12 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
4.49% less ownership
Funds ownership: 7.43% → 2.94% (-4.5%)
16% less capital invested
Capital invested by funds: $483K → $404K (-$78.5K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$38.9K |
| 2 |
UFA
US Financial Advisors
Braintree,
Massachusetts
|
+$24.7K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$17.1K |
| 4 |
Morgan Stanley
New York
|
+$7.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.08K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$233K |
| 2 |
Renaissance Technologies
New York
|
-$34K |
| 3 |
Two Sigma Investments
New York
|
-$25.1K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$2.88K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$742 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Geode Capital Management
Boston,
Massachusetts
| $106K | +$17.1K | +11,880 | +29% |
|
|
WA
2
Wealth Alliance
Mellville,
New York
| $81.2K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $56.5K | +$38.9K | +26,973 | +3,211% |
|
4
Vanguard Group
Malvern,
Pennsylvania
| $41.6K | – | – | – |
|
5
State Street
Boston,
Massachusetts
| $41.5K | – | – | – |
|
|
UFA
6
US Financial Advisors
Braintree,
Massachusetts
| $34.8K | +$24.7K | +17,142 | New |
|
|
7
Morgan Stanley
New York
| $30.4K | +$7.2K | +5,000 | +50% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $9.73K | +$3.08K | +2,134 | +80% |
|
|
9
Wells Fargo
San Francisco,
California
| $1.96K | -$742 | -515 | -35% |
|
|
10
Osaic Holdings
Scottsdale,
Arizona
| $391 | -$2.88K | -2,001 | -91% |
|
11
Bank of America
Charlotte,
North Carolina
| $95 | +$68 | +47 | New |
|
|
JWM
12
Janiczek Wealth Management
Denver,
Colorado
| $3 | +$1 | +1 | New |
|
|
SM
13
Sabby Management
Miami Beach,
Florida
| – | -$233K | -168,544 | Closed |
|
|
14
Renaissance Technologies
New York
| – | -$34K | -24,861 | Closed |
|
|
15
Two Sigma Investments
New York
| – | -$25.1K | -18,167 | Closed |
|
BRTX Hedge Fund Activity: Q2 2024 in Review
12 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in BioRestorative Therapies (BRTX) for Q2 2024, worth a combined $404K — down 16% from $483K a quarter earlier.
Fund positioning in BRTX was balanced in Q2 2024: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 2 trimmed.
The largest buyer was UBS Group, adding an estimated $38.9K. The largest seller was Sabby Management, exiting entirely with an estimated $233K sold.
- 12 institutional investors held BioRestorative Therapies (BRTX) as of Q2 2024, unchanged from Q1 2024.
- Funds reported $404K of BioRestorative Therapies stock for Q2 2024, down 16% quarter-over-quarter.
- 3 funds opened new BioRestorative Therapies positions in Q2 2024 and 3 closed out, a net change of 0 holders.
- The largest BioRestorative Therapies buyer in Q2 2024 was UBS Group, an estimated $38.9K added.
- The largest BioRestorative Therapies seller in Q2 2024 was Sabby Management, an estimated $233K sold.
Based on aggregated 13F filings for Q2 2024.